titration of tirzepatide Overview Initial Tirzepatide Dose & Titration

These can disrupt gut microbiota and digestion

Based on observational data, a 2011 report identified an increased risk for pancreatitis and pancreatic cancer in patients on incretin therapy 4 , which led to a Food and Drug Administration (FDA) warning on the pancreatic safety of GLP-1 agonists 5

10.1093/japr/16.1.126 89

Mann, MD, a professor of medicine at the Friedrich Alexander University of Erlangen, Germany, and senior international scholar at the Population Health Research Institute at McMaster University in Hamilton, Canada, said in a press release

R-Y W, Y-X S, Zeng Z, Schober WD, McQueen TJ, Hopwood VL, Korchin B, Konopleva M, Andreeff M

Start Your GLP-1/GIP Program Today